I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 4 studies | 17% ± 1% | |
| fibroblast | 4 studies | 23% ± 6% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 18% ± 1% | |
| CD4-positive, alpha-beta T cell | 3 studies | 20% ± 1% | |
| CD8-positive, alpha-beta T cell | 3 studies | 18% ± 1% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 18% ± 1% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 17% ± 2% | |
| epithelial cell | 3 studies | 29% ± 10% | |
| endothelial cell | 3 studies | 24% ± 8% | |
| ciliated cell | 3 studies | 22% ± 1% | |
| oligodendrocyte | 3 studies | 19% ± 2% |
